From our Center

Articles, News, Press Releases

Summer 2021

Andrew Sweatt, MD

Roham Zamanian, MD, FCCP

Marlene Rabinovitch, MD

Congratulations Drs. Sweatt, Zamanian and Rabinovitch!

Congratulations to Wall Center Facuty Andrew Sweatt, MD, Clinical Assistant Professor of Medicine in Pulmonary, Allergy, and Critical Care Medicine, Roham Zamanian, MD, Associate Professor in the Division of Pulmonary, Allergy and Critical Care Medicine and Director of the Adult Pulmonary Hypertension Program, and Marlene Rabinovitch, MD, Dwight and Vera Dunlevie Professor of Pediatrics, Cardiology, in their collaborative effort on the article Severe Pulmonary Arterial Hypertension Is Characterized by Increased Neutrophil Elastase and Relative Elafin Deficiency, recently published in Chest.

Subscribe to our eNews

COVID-19


Roham Zamanian, MD, FCCP

Special Edition phaware® Podcast with Dr. Roham Zamanian  

Our friends at phaware® shared a special edition podcast with Roham Zamanian, MD, FCCP, Associate Professor in the Division of Pulmonary, Allergy and Critical Care Medicine and Director of the Adult Pulmonary Hypertension Program,  discussing the coronavirus (COVID-19) and gives specific advice for the PH Community.


Vinicio de Jesus Perez, MD and Roham Zamanian, MD, FCCP

Congratulations to Vinicio de Jesus Perez and Roham Zamanian for a High Impact COVID-19 Story

Roham Zamanian, MD, FCCP, Associate Professor in the Division of Pulmonary, Allergy and Critical Care Medicine and Director of the Adult Pulmonary Hypertension Program and Vinicio de Jesus Perez, MD, Associate Professor of Medicine in Pulmonary, Allergy, and Critical Care Medicine, along with other distinguished colleagues, published their fascinating case report in the American Journal of Respiratory and Critical Care Medicine detailing the outpatient management of a patient with concomitant idiopathic pulmonary arterial hypertension (iPAH) and COVID-19 disease using inhaled nitric oxide (iNO).

Kristina Kudelko, MD

What our Pulmonary Hypertension (PH) Patients Should Know About COVID-19

Kristina Kudelko, MD, Clinical Associate Professor in the Division of Pulmonary, Allergy and Critical Care Medicine shares important information regarding pulmonary hypertension and COVID-19.


Roham Zamanian, MD, FCCP

Care of patients with Pulmonary Arterial Hypertension during the Coronavirus (COVID-19) Pandemic  

Roham Zamanian, MD, FCCP, Associate Professor in the Division of Pulmonary, Allergy and Critical Care Medicine and Director of the Adult Pulmonary Hypertension Program, along with leading pulmonary hypertension clinicians published an express manuscript about caring for PH patients with COVID-19.

 More 

Abstract: The COVID-19 pandemic presents many unique challenges when caring for patients with pulmonary hypertension (PH).The COVID-19 pandemic has altered routine standard of care practice and the acute management particularly for those patients with pulmonary arterial hypertension (PAH), where PAH-specific treatments are used. It is important to balance the ongoing care andevaluation of PAH patients with “exposure risk” to COVID-19 for patients coming to clinic or the hospital. If there is a morbidity and mortality benefit from starting PAH therapies, for example in a patient with high-likelihood of PAH, then it remains important to complete the thorough evaluation. However, the COVID-19 outbreak may also represent a unique time when PH experts have to weigh the risks and benefits of the diagnostic work-up including potential exposure to COVID-19 versus initiatingtargeted PAH therapy in a select high-risk, highlikelihood World Symposium Pulmonary Hypertension (WSPH) Group 1 PAH patients.This document will highlight some of the issues facing providers, patients and the PAH community in real-time as the COVID-19 pandemic isevolving and is intended to share expected common clinical scenarios and best clinical practices to help the community at-large.

 Less